Interim Analysis of 48-week Tenofovir Amibufenamide Treatment in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels: The PROMOTE Study.

J Clin Transl Hepatol · 2025 · PMC12422148 · PMID 40937079

Europe PMC DOI

hedged sentence

0.9310

closest p · 18.6× alpha

0.9310

boldest claim

The sentences

did not reach statistical significanceP = 0.931not close (p > 0.1)

Although TMF treatment showed trends toward numerical improvement in liver stiffness, these differences did not reach statistical significance ( P = 0.931 and P = 0.81, respectively, Supplementary Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.